» Articles » PMID: 24066661

Hormone Variations Associated with Quantitative Fat Measures in the Menopausal Transition

Overview
Journal Climacteric
Publisher Informa Healthcare
Date 2013 Sep 27
PMID 24066661
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Reproductive hormone levels are associated with body size, and the association between estradiol and body size varies over the menopausal transition. This study aims to delineate these relationships using quantitative measures of visceral and subcutaneous fat.

Methods: Early follicular hormones (follicle stimulating hormone (FSH), estradiol, luteinizing hormone, dehydroepiandrosterone sulfate, testosterone) and T-1 weighted abdominal MRI images were obtained in a cross-sectional assessment of 77 women in the Penn Ovarian Aging Study. Fat volume (cm(3)) was quantified using validated software (Amira) and divided into tertiles of visceral and subcutaneous fat volume for analysis. Multivariable linear regression models compared hormone values between tertiles adjusting for race, age, and menopausal status.

Results: In adjusted models, estradiol was positively associated with visceral fat tertiles (geometric mean (GM) estradiol (pg/ml): Low 13.0, Mid 17.5, High 26.7, p = 0.006) while FSH was inversely associated with visceral fat tertiles (GM FSH (mIU/ml): Low 42.8, Mid 43.2, High 30.8, p = 0.03). The association of estradiol with visceral and subcutaneous fat tertiles varied by menopausal status (p < 0.001). In the early transition, estradiol was similar across tertiles of fat; postmenopause, estradiol was positively associated with visceral fat. Other hormones were not associated with fat measures.

Conclusions: Estradiol was associated with quantitative measures of visceral fat and varies by menopausal status. This finding suggests that visceral fat may be an important mediator in hormone changes over the menopausal transition.

Citing Articles

Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.

Bergamini M, Dalla Volta A, Palumbo C, Zamboni S, Triggiani L, Zamparini M Elife. 2024; 13.

PMID: 38656229 PMC: 11042799. DOI: 10.7554/eLife.92655.


Periovarian Adipose Tissue - an Impact on Ovarian Functions.

Szyrzisko W, Grzesiak M Physiol Res. 2024; 73(1):1-8.

PMID: 38466000 PMC: 11019623. DOI: 10.33549/physiolres.935206.


Serum Follicle-Stimulating Hormone and 5-Year Change in Adiposity in Healthy Postmenopausal Women.

Mattick L, Bea J, Singh L, Hovey K, Banack H, Wactawski-Wende J J Clin Endocrinol Metab. 2022; 107(8):e3455-e3462.

PMID: 35435955 PMC: 9282244. DOI: 10.1210/clinem/dgac238.


FSH Level and Changes in Bone Mass and Body Composition in Older Women and Men.

Wu K, Ewing S, Li X, Sigurdsson S, Gudnason V, Kado D J Clin Endocrinol Metab. 2021; 106(10):2876-2889.

PMID: 34212197 PMC: 8475206. DOI: 10.1210/clinem/dgab481.


Serum FSH Is Associated With BMD, Bone Marrow Adiposity, and Body Composition in the AGES-Reykjavik Study of Older Adults.

Veldhuis-Vlug A, Woods G, Sigurdsson S, Ewing S, Le P, Hue T J Clin Endocrinol Metab. 2020; 106(3):e1156-e1169.

PMID: 33326040 PMC: 7947831. DOI: 10.1210/clinem/dgaa922.